Real ‐World Opportunity of Empagliflozin to Improve Blood Pressure Control in African Americans with Type 2 Diabetes: An NCDR® “Research‐to‐Practice” Project From the Diabetes Collaborative Registry (DCR)

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Suzanne V. Arnold MD MHA , Leo Seman MD PhD , Fengming Tang MS , Poghni A. Peri ‐okonny MD , Keith C. Ferdinand MD , Sanjeev N. Mehta MD MPH , Abhinav Goyal MD MHS , Laurence S. Sperling MD , Mikhail Kosiborod MD Source Type: research